Colorectal cancer DNA vaccine (Cellectis/Karolinska Institute)

N/A

Report date: 2022/07/04 19:38:02

Base Information

Drug NameColorectal cancer DNA vaccine (Cellectis/Karolinska Institute)
Drug Alias Name大肠癌DNA疫苗 - Cellectis/卡罗琳学院tetwtCEA DNA大肠肿瘤DNA疫苗 - Cellectis/卡罗琳学院Carcinoembryonic antigen DNA vaccine
ClassificationVaccines > Application > Therapeutic vaccineVaccines > Development/production technology > Nucleic acid vaccine > DNA vaccine
Mechanisms of ActionImmunostimulantsCarcinoembryonic antigen stimulants
TargetsCarcinoembryonic antigen
Therapy Area/IndicationsColorectal Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySweden
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesKarolinska InstitutetCyto Pulse Sciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesKarolinska InstitutetCyto Pulse Sciences Inc
Active IndicationsN/A
Inactive IndicationsColorectal Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A